knowledge -WSS

knowledge

author：focus 2025-09-06 03:39:46 - browse：55

Adobe

The federal government inappropriately lowered the 2024 Medicare Advantage star ratings of SCAN Health Plan, which led to the health insurance company in California losing hundreds of millions of dollars in bonuses from the government, a judge ruled Monday.

The decision will lead to more than $250 million funneling back into SCAN, which covers 270,000 Medicare Advantage enrollees. And it opens the door for other Medicare Advantage plans to potentially recoup huge sums of taxpayer-funded bonuses — even though many independent experts believe the quality rating system is flawed and doesn’t appropriately gauge quality of care for older adults and people with disabilities.

The Centers for Medicare and Medicaid Services, the federal agency that oversees all Medicare programs, said it does not comment on litigation. In an interview, SCAN CEO Sachin Jain told STAT that if the company had not gotten its expected bonus money, it would have had to shave benefits and reduce what it pays hospitals and doctors.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Micronoma's microbiome cancer diagnostic approach under fire

knowledge

WSS

New details revealed about Purdue's marketing of OxyContin

National panel will explore requiring free Covid tests

What the US credit downgrade means for the economy, your finances

What the US credit downgrade means for the economy, your finances

What the airline industry can learn from medicine

Pence says 'crackpot lawyers' told Trump what he wanted to hear

knowledge

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

leisure time

How one medical school became remarkably diverse

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Psychedelics group wrestles with new pharma identity

Patient advocates sound warning on FDA proposal on salt intake

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

As Maui death toll rises, number of missing remains unclear

Tori Bowie and the unacceptable rates of Black maternal death

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Drug repurposing or repositioning? The language matters

Listen: Racing for gene therapy & a pioneering approval

hotspot

Eye stem cell transplant could help restore vision in injured people

Clinical trials must include more disabled people

Listen: Racing for gene therapy & a pioneering approval

Trump indictment: Who are the 'co

Living with Hashimoto's and celiac disease, and med school, too

An interview with Robert F. Kennedy Jr. on vaccines

focus

knowledge

explore

entertainment